Bionano Genomics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $8,171 | $6,687 | $7,951 | $7,367 |
Gross Profit | 4,314 | 3,252 | 3,399 | 3,370 |
EBITDA | -5,120 | -5,859 | -5,438 | -5,993 |
EBIT | -7,416 | -8,220 | -7,826 | -8,420 |
Net Income | -7,423 | -8,303 | -7,933 | -8,503 |
Net Change In Cash | 8,171 | 6,687 | 7,951 | 7,367 |
Free Cash Flow | -4,670 | -5,716 | -4,175 | -5,919 |
Cash | 3,730 | 13,691 | 2,990 | 3,065 |
Basic Shares | 11,546 | 10,979 | 10,740 | 5,338 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $28,508 | $30,776 | $36,116 | $27,802 |
Gross Profit | 6,258 | 380 | 9,566 | 5,945 |
EBITDA | -16,299 | -97,469 | -213,604 | -120,315 |
EBIT | -26,030 | -111,695 | -227,312 | -130,414 |
Net Income | -26,395 | -112,017 | -232,493 | -132,596 |
Net Change In Cash | 28,508 | 30,776 | 36,116 | 27,802 |
Cost of Revenue | -19,042 | |||
Free Cash Flow | -16,345 | -69,025 | -126,872 | -128,118 |
Cash | 2,990 | 9,173 | 17,948 | 5,091 |
Basic Shares | 5,445 | 1,270 | 569 | 482 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.64 |
2026-03-31 | -$0.75 |
2025-12-31 | -$0.03 |
2025-09-30 | -$1.59 |